Company Profile of Tianjin Huairen Pharmaceutical Co., Ltd.

Since its establishment, the company has taken advantage of its strong technology to actively explore the pharmaceutical market, accelerate the research, development and promotion of self-developed and domestic and foreign new drugs, and contribute to my country's health care industry.

The company is registered in Xiqing Economic Development Zone, Tianjin, and is a high-tech enterprise recognized by the Tianjin Science and Technology Commission. A garden-style modern pharmaceutical enterprise that complies with GMP standards has been built in the park. The investment in the first phase of the project is nearly 40 million yuan, covering an area of ??60 acres and a construction area of ??6,000 square meters. It can produce API, tablets, capsules, granules and other dosage forms.

The company has many well-known domestic experts and senior talents in traditional Chinese medicine, biology, pharmacy, management, etc., including experts from the Institute of Hematology, Chinese Academy of Medical Sciences, and has established a high-quality team. The technical and management teams ensure the company's development and new drug research and development. Relying on its outstanding talents, abundant funds, advanced equipment and technological advantages, the company quickly researches new drug varieties and new dosage forms and transforms research results into products, continuously providing the company with market competitive new drug varieties.

The company’s first drug, iron dextran raw materials and tablets, is one of the results of years of research by the Institute of Hematology, Chinese Academy of Medical Sciences. Iron deficiency anemia is a common disease among the general population, especially women and children. The prevalence rate in my country and some developing countries is as high as 30-90%. The iron dextran raw materials and tablets produced by our company have advanced production technology. The products are of high quality, easy to absorb, and have fast curative effect. They do not have the gastrointestinal side effects of general iron preparations, which have been confirmed by a large number of patients. Therefore, they are the ideal replacement for the current general iron preparations. The ideal new product for agents.

The second-class new drug produced by the company - Telmisartan Tablets is the most ideal antihypertensive drug for the majority of patients with hypertension. It has the characteristics of only taking medicine once a day, stably lowering blood pressure, and having few side effects. Its biggest advantage is that it is highly safe, and its adverse reactions are mild and transient. Generally, it does not require discontinuation of medication, and it can achieve the purpose of stably lowering blood pressure. At the same time, the drug has significant clinical efficacy. Using it or a combination treatment based on it can effectively lower blood pressure and maintain blood pressure control. At the same time, using Telmisartan Tablets to lower blood pressure is more ideal for patients with diabetic nephropathy (DN). , it can significantly delay the development of diabetes in patients with hypertension, reduce the occurrence of protein, and prevent diabetes and kidney disease. Therefore, Telmisartan Tablets are a long-acting, highly effective, low-toxic new AT antagonist, suitable for various hypertensive patients who are intolerant or allergic to other antihypertensive drugs, and are considered to have clinical value. Very high first line drug. Other products are gradually accepted by the majority of patients for their high quality and good efficacy. Among them, ambroxol hydrochloride tablets and fluconazole capsules were selected into the "National Essential Medicines List" (2009 edition), and the products are sold well all over the country.